Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Moxidectin: From Anthelmintic to Assay Insight
2026-09-14
Moxidectin is a macrocyclic lactone anthelmintic with established veterinary utility and emerging antifungal relevance. This evidence-focused guide explains how its Candida–polyene synergy should shape assay design, interpretation, and translational expectations.
-
LMO2–LDB1 Signaling in Acute Myeloid Leukemia
2026-09-14
The reference study identifies an LMO2/LDB1 protein complex as an important transcriptional driver of acute myeloid leukemia (AML) cell maintenance. Through gene perturbation, protein-interaction analysis, transcriptomics, chromatin profiling, and in vivo validation, the authors show that LDB1 supports AML proliferation and survival partly through LMO2-regulated programs.
-
Deferasirox: Iron Chelation Research Workflows
2026-09-13
Deferasirox offers a practical way to perturb labile iron while connecting iron-overload biology with ferroptosis-focused cancer research. This workflow guide covers concentration design, oxygen-aware interpretation, ferroptosis readouts, and troubleshooting for HCC and hematopoietic models.
-
Masitinib (AB1010): KIT/PDGFR Workflow Guide
2026-09-12
Masitinib (AB1010), SKU A2942, is a DMSO-compatible tyrosine kinase inhibitor for focused KIT, PDGFRα, PDGFRβ, mast-cell, and selected GIST research. It is appropriate for defined cellular or biochemical workflows, but not for aqueous or ethanol-based assays, broad-spectrum kinase studies, or clinical treatment decisions.
-
BMS 309403: A Practical FABP4 Inhibitor Workflow
2026-09-11
BMS 309403 provides a selective pharmacological entry point for testing how FABP4 connects fatty acid handling, macrophage inflammation, and foam cell formation. This workflow translates mechanistic findings into reproducible cell-based assays for atherosclerosis, metabolic disease, and type 2 diabetes research.
-
HyperFluor™ 488 Antibody for Hypoxia Assays
2026-09-11
Learn how HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody supports spatially resolved hypoxia research, from PHD2/HIF-1α/EPO staining to orthogonal tissue validation. This guide translates the ginsenoside study into practical decisions for fluorescence, Western blot, flow cytometry, and histology workflows.
-
Carbapenemase Transmission in CREC Across Guangdong
2026-09-10
A 2025 BMC Microbiology study characterized carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight teaching hospitals in Guangdong, China. Its combination of gene localization, conjugation testing, mobile-element analysis, antimicrobial susceptibility testing, and ERIC-PCR links plasmid-mediated horizontal transfer with clonal dissemination and multidrug resistance.
-
Wortmannin Workflows for PI3K and Autophagy
2026-09-10
Wortmannin enables controlled interrogation of PI3K-dependent signaling, autophagy, and cell death in infection and cancer models. This workflow connects macrophage experiments inspired by Entamoeba histolytica research with practical controls, dosing logic, and troubleshooting for reproducible pathway studies.
-
Hematoxylin and Eosin Staining Kit Guide
2026-09-09
The Hematoxylin and Eosin Staining Kit (SKU K1142) provides ready-to-use hematoxylin and eosin solutions for visualizing nuclei, cytoplasm, extracellular matrix, and overall tissue architecture. It is intended for research workflows involving paraffin-embedded or frozen sections and cytological preparations, not clinical diagnosis or medical use.
-
Tariquidar: Testing Mechanical Chemoresistance
2026-09-09
Tariquidar (XR9576) is a powerful tool for separating P-glycoprotein activity from mechanically driven transporter upregulation. This article explains how viscosity-sensitive TRPV4–YAP signaling reshapes assay design, concentration selection, and interpretation in drug resistance research.
-
HotStart Universal 2X FAST Green qPCR Master Mix Workflow
2026-09-08
Translate the hly–biofilm findings in Listeria monocytogenes into a practical RT-qPCR workflow for comparing virulence, quorum-sensing, and stress-response transcripts. This guide shows how a fast hot-start polymerase, inhibitor tolerance, ROX normalization, and melt curve analysis can improve confidence in dye-based gene expression analysis.
-
Mitomycin C Workflows for DNA Damage Assays
2026-09-08
Mitomycin C is an antitumor antibiotic that combines direct DNA adduct stress with strong utility in apoptosis and combination-treatment experiments. This guide translates its chemistry into concentration-response, TRAIL-sensitization, DNA-repair, and biomarker-aware workflows while emphasizing formulation control and assay troubleshooting.
-
Alcian Blue & Nuclear Fast Red Staining Kit: Guide
2026-09-07
Learn how the Alcian Blue & Nuclear Fast Red Staining Kit pH2.5 distinguishes acid-rich extracellular matrix from cellular morphology. This decision-focused guide connects staining chemistry, chondrogenic assay interpretation, and small-tissue preanalytics without confusing visibility with biological specificity.
-
ABT-263 (Navitoclax): From Apoptosis to Translation
2026-09-07
ABT-263 (Navitoclax) is more than a potent Bcl-2 family inhibitor: it is a decision tool for mapping mitochondrial dependence, designing stronger apoptosis assays, and testing translational hypotheses across oncology and systemic aging research.
-
Luminescent ATP Cell Viability Assay Kit I for Ferroptosis
2026-09-05
Discover how the Luminescent ATP Cell Viability Assay Kit I can clarify ATP loss during RSL3-driven ferroptosis research. This article connects mitochondrial zinc biology with rigorous cell viability measurement, assay controls, and interpretation limits.